Click me to open the menu
Click me to close the menu

THCv - an abject cop-out from the ACMD, another research opportunity for the UK lost

24th January 2017

The ACMD has voted to keep THCv, a non-psychoactive cannabinoid with a promising properties for a range of health conditions, in Schedule 1 away from the hands of researchers.

How the law against synthetic cannabinoids might destroy pharmaceutical discovery in the UK

4th January 2017

In an effort to curb the current wave of recreational synthetic cannabinoids, the Government have introduced new controls for a range of core chemical structures. These structures are also found in many pharmaceuticals and could stifle future pharmaceutical development

The UK needs common sense about ketamine

18th February 2015

Will new drug driving law reduce minimise harm?

2nd August 2013

There's more than one way to skin a cat

3rd July 2013

The Dustbin of Schedule 1: How Schedule 1 control may stifle medical advances

23rd January 2013

  • DrugScience
  • 2 Langley Lane
  • London
  • SW8 1GB
  • info@drugscience.org.uk